1. Most Discussed
  2. Gainers & Losers
ANP 2.2¢

PJ Trainer Endo 2105

  1. kpkg

    4,149 Posts.

    Professor Trainer to present on atl1103
    "This study provides proof-of-concept that ATL1103 is able to significantly lower IGF-I in patients with acromegaly and offers a novel therapeutic approach."
    ....and no wonder after maintaining a 20% igf-1 reduction 2 complete months after dosing ended.
    Now you can stamp your feet and jump up and down all you like, post lots of rubbish about marketing this and marketing that, but its all irrelevant at this point in time. Atl1103 will be a new novel therapy and when they have deal signed you will all know about it.
    The guidance has been given and until they a) either sign a deal/receive a t/o bid, or b) adjust the expected timeline , then everything is as it should be with the expectation that a deal will be signed in the very immediate short term.

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.